TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 153 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,628,000 | +3.8% | 119,960 | +8.9% | 0.00% | 0.0% |
| Q3 2016 | $12,169,000 | -18.1% | 110,119 | +7.9% | 0.00% | -33.3% |
| Q2 2016 | $14,853,000 | +86.3% | 102,011 | +83.3% | 0.00% | +50.0% |
| Q1 2016 | $7,972,000 | +1.6% | 55,651 | +9.6% | 0.00% | 0.0% |
| Q4 2015 | $7,847,000 | +112000.0% | 50,772 | +105675.0% | 0.00% | – |
| Q3 2014 | $7,000 | 0.0% | 48 | -5.9% | 0.00% | – |
| Q2 2014 | $7,000 | +16.7% | 51 | 0.0% | 0.00% | – |
| Q1 2014 | $6,000 | +20.0% | 51 | 0.0% | 0.00% | – |
| Q4 2013 | $5,000 | -98.4% | 51 | -98.7% | 0.00% | – |
| Q3 2013 | $304,000 | +54.3% | 4,003 | +13.5% | 0.00% | – |
| Q2 2013 | $197,000 | – | 3,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |